Alector, Inc. ( ALEC) - Key Metrics
ALEC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.06 | -$0.36 | -$0.40 | -$0.40 |
| 2025Q3 | $0.03 | -$0.34 | -$0.32 | -$0.32 |
| 2025Q2 | $0.08 | -$0.30 | -$0.49 | -$0.49 |
| 2025Q1 | $0.04 | -$0.41 | -$0.61 | -$0.61 |
| 2024Q4 | $0.55 | -$0.02 | -$0.56 | -$0.56 |
ALEC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -1.08 |
| 2025Q3 | ? | -2.19 |
| 2025Q2 | ? | -1.15 |
| 2025Q1 | ? | -0.76 |
| 2024Q4 | ? | -22.40 |
ALEC
Price: $1.54
52 week price:
Earnings Per Share: -1.39 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 209662
Market Capitalization: 197.1 million